Skip to main content
. 2015 Feb 26;8(1):113–121. doi: 10.1159/000371720

Fig. 2.

Fig. 2

Changes in LFTs with TDM-1 treatment. Serum bilirubin (μmol/l), alanine transaminase (U/l) and alkaline phosphatase (U/l) levels are shown. The normal ranges (NR) for bilirubin, alanine transaminase and alkaline phosphatase are <17 µmol/l, <40 U/l and 24–110 U/l, respectively. Each cycle of TDM-1 treatment is shown along with its cycle number, dose and any dose reduction instituted. Day 0 represents the administration of the first cycle of TDM-1.